Cosmos Health Inc. last reported quarterly results on Oct 9, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026). It usually reports 9–51 days after a quarter ends. Based on that pattern, the next release is estimated for around Feb 17, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Wednesday. Based on how many days after a quarter ends the company has reported recently. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 9–51 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 9, 2026
9 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
—
|
—
|
—
|
|
Aug 20, 2026
51 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
19
+28.8%
|
-6
-115.2%
|
-0.10
+0.0%
|
|
Apr 16, 2026
16 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
18
+30.7%
|
-3
-242.9%
|
-0.06
-100.0%
|
|
Nov 17, 2025
48 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
17
+37.9%
|
-5
+36.1%
|
-0.17
+62.2%
|
|
Nov 22, 2023
53 days after quarter end
|
—
ended Sep 30, 2023
|
—
|
—
|
—
|
|
Aug 15, 2023
46 days after quarter end
|
—
ended Jun 30, 2023
|
—
|
—
|
—
|
|
Apr 18, 2023
18 days after quarter end
|
—
ended Mar 31, 2023
|
—
|
—
|
—
|
|
Nov 16, 2022
47 days after quarter end
|
—
ended Sep 30, 2022
|
—
|
—
|
—
|
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- COSM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Thessaloniki, Greece
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1474167
- Former names
- Cosmos Holdings Inc. (until Dec 19, 2022); PRIME ESTATES & DEVELOPMENTS INC (until Jan 3, 2014)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- DataMeds AI, Inc. MEDS
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.